Autologous transplantation of RPE with partial-thickness choroid after mechanical debridement of bruch membrane in the rabbit

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 7, 2008, Pages 3185-3192

  Hu, Yuntao ^a   Zhang, Taoran ^a   Wu, Jianguo ^a   Li, Ying ^a   Lu, Xinrong ^a   Qian, Fang ^a   Yin, Zhengqin ^b   Ma, Zhizhong ^a  

^a PEKING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FLUORESCEIN; RETINOID BINDING PROTEIN; RHODOPSIN; VISUAL PIGMENT;

ABRASION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BRUCH MEMBRANE; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DEBRIDEMENT; EPITHELIUM CELL; EYE INJURY; FLUORESCENCE ANGIOGRAPHY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OPHTHALMOSCOPY; PARTIAL THICKNESS CHOROID GRAFT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RABBIT; RETINA NEUROEPITHELIAL LAYER; TISSUE GRAFT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD VESSEL; CHOROID; ELECTRON MICROSCOPY; EYE FUNDUS; GRAFT SURVIVAL; METABOLISM; PATHOLOGY; PHOTORECEPTOR; RETINA; TRANSPLANTATION; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; BRUCH MEMBRANE; CHOROID; DEBRIDEMENT; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; PHOTORECEPTORS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; RABBITS; RETINA; RHODOPSIN; TRANSPLANTATION, AUTOLOGOUS;

EID: 48249112154     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1299     Document Type: Article

References (92)

1. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9):1220-1231.
2. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9):1232-1241.
3. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol. 1991;109(9):1242-1257.
4. Coscas G, Soubrane G, Ramahefasolo C, Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9):1258-1265.
5. Rechtman E, Ciulla TA, Criswell MH, Pollack A, Harris A. An update on photodynamic therapy in age-related macular degeneration. Expert Opin Pharmacother. 2002;3(7):931-938. (Pubitemid 34752510)
6. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation. Eye. 2001;15(pt 3):407-412. (Pubitemid 32600866)
7. Wygnanski-Jaffe T, Desatnik H, Alhalel A, et al. ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2006;37(5):358-363. (Pubitemid 44519239)
8. Fraunfelder FW. Pegaptanib for wet macular degeneration. Drugs Today. 2005;41(11):703-709. (Pubitemid 43074780)
9. Konderding MA. Ocular angiogenesis: translating preclinical indications to successful clinical development. Expert Opin Ther Targets. 2004;8(3):255-258. (Pubitemid 38877675)
10. Ng EWM, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol. 2005;40(3):352-368. (Pubitemid 40942262)
11. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;112(6):1035-1047. (Pubitemid 40797459)
12. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36(4):331-335. (Pubitemid 41073112)
13. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevazicumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113(3):363-372. (Pubitemid 43296975)
14. Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci. 2005;46(2):726-733. (Pubitemid 40270359)
15. Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006;113(4):642.e1-e4.
16. Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology. 2005;112(6):1048-1053. (Pubitemid 40797460)
17. Kim IK, Husain D, Michaud N, et al. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006;47(1):357-363. (Pubitemid 46780836)
18. Grossniklaus HE, Hutchinson AK, Capone A, Woolfson J, Lambert HM. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 1994;101(6):1099-1111. (Pubitemid 24183168)
19. Lopez PE, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112(6):647-656.
20. Gass JD. Biomicroscopic and histologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118(3):285-298. (Pubitemid 24281720)
21. Thomas MA, Kaplan HJ. Surgical removal of subfoveal choroidal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1991;111(1):1-7.
22. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 1994;101(8):1384-1396. (Pubitemid 24319287)
23. Eckstein M, Wells JA, Aylward GW, Gregor Z. Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye. 1998;12(pt 5):775-780. (Pubitemid 28482797)
24. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 2002;120(4):451-459. (Pubitemid 34727816)
25. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology. 2005;112(1):144-151. (Pubitemid 40075334)
26. Toth CA, Lapolice DJ, Banks AD, Stinnett SS. Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol. 2004;242(7):541-548. (Pubitemid 39157681)
27. Pieramici DJ, De Juan E Jr, Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2000;130(4):419-428. (Pubitemid 30759195)
28. Park CH, Toth CA. Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization. Am J Ophthalmol. 2003;136(5):830-835. (Pubitemid 37330025)
29. Akduman L, Karavellas MP, MacDonald JC, Olk RJ, Freeman WR. Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration. Retina. 1999;19(5):418-423. (Pubitemid 30387513)
30. Lewis H, Kaiser PK, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am J Ophthalmol. 1999;128(2):135-146. (Pubitemid 29379765)
31. Freedman SF, Holgado S, Enyedi LB, Toth CA. Management of ocular torsion and diplopia after macular translocation for age-related macular degeneration: prospective clinical study. Am J Ophthalmol. 2003;136(4):640-648. (Pubitemid 37153178)
32. Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. 2003;87(5):615-621. (Pubitemid 36535337)
33. Fujii GY, Pieramici DJ, Humayun MS, et al. Complications associated with limited macular translocation. Am J Ophthalmol. 2000;130(6):751-762. (Pubitemid 32000856)
34. Buffenn AN, de Juan E, Fujii G, Hunter DG. Diplopia after limited macular translocation surgery. J AAPOS. 2001;5(6):388-394. (Pubitemid 33601326)
35. Schraermeyer U, Kociok N, Heimann K. Rescue effects of IPE transplants in RCS rats: short-term results. Invest Ophthalmol Vis Sci. 1999;40(7):1545-1556. (Pubitemid 29252346)
36. Geng L, Wihlmark U, Algvere PV. Lipofuscin accumulation in iris pigment epithelial cells exposed to photoreceptor outer segments. Exp Eye Res. 1999;69(5):539-546.
37. Sakuragi M, Tomita H, Abe T, Tamai M. Changes of phagocytic capacity in basic fibroblast growth factor-transfected iris pigment epithelial cells in rats. Curr Eye Res. 2001;23(3):185-191. (Pubitemid 34497358)
38. Dintelmann TS, Heimann K, Kayatz P, Schraermeyer U. Comparative study of ROS degradation by IPE and RPE cells in vitro. Graefes Arch Clin Exp Ophthalmol. 1999;237(10):830-839. (Pubitemid 29438465)
39. Crafoord S, Geng L, Seregard S, Algvere PV. Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol Scand. 2002;80(4):387-394. (Pubitemid 34906604)
40. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. 1999;9(3):217-230. (Pubitemid 29493608)
41. Grisanti S, Ishioka M, Kosiewicz M, Jiang LQ. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants. Invest Ophthalmol Vis Sci. 1997;38(8):1619-1626. (Pubitemid 27317858)
42. Del Priore LV, Kaplan HJ, Tezel TH, Hayashi N, Berger AS, Green WR. Retinal pigment epithelial cell transplantation after subfoveal membranectomy in age-related macular degeneration: clinicopathologic correlation. Am J Ophthalmol. 2001;131(4):472-480. (Pubitemid 32273434)
43. Weisz JM, Humayun MS, De-Juan E Jr, et al. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina. 1999;19(6):540-545. (Pubitemid 30387490)
44. Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci. 1998;39(6):1021-1027. (Pubitemid 28196688)
45. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002;133(2):215-225. (Pubitemid 34072050)
46. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45(11):4151-4160. (Pubitemid 39411174)
47. Van Meurs JC, ter Averst E, Hofland LJ, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. 2004;88(1):110-113. (Pubitemid 38091375)
48. Phillips SJ, Sadda SR, Tso MO, Humayan MS, de Juan E, Binder S. Autologous transplantation of retinal pigment epithelium after mechanical debridement of Bruch's membrane. Curr Eye Res. 2003;26(2):81-88. (Pubitemid 36776114)
49. Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC Jr, Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22(2):102-108.
50. Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int Ophthalmol. 2001;23(4-6):297-307. (Pubitemid 34256594)
51. Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology. 2002;109(8):1492-1498. (Pubitemid 34885879)
52. Van Meurs JC, van Den Biesen PR. Autologous retinal pigment epithelium and choroids translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003;136(4):688-695. (Pubitemid 37153184)
53. Joussen AM, Heussen FM, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2006;142(1):17-30. (Pubitemid 43946784)
54. Joussen AM, Joeres S, Fawzy N, et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology. 2007;114(3):551-560. (Pubitemid 46282952)
55. Treumer F, Bunse A, Klatt C, Roider J. Autologous retinal pigment epithelium-choroid sheet transplantation in age related macular degeneration: morphological and functional results. Br J Ophthalmol. 2007;91(3):349-353. (Pubitemid 46586533)
56. MacLaren RE, Uppal GS, Balaggan KS, et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007;114(3):561-570. (Pubitemid 46282940)
57. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005;112(12):2081-2087. (Pubitemid 41720984)
58. Yepez JB, Arevalo JF. RPE translocation in ARMD. Ophthalmology. 2003;110(11):2262. (Pubitemid 37337872)
59. Stanzel BV, Espana EM, Grueterich M, et al. Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res. 2005;80(1):103-112. (Pubitemid 40126518)
60. Ohno Matsui K, Ichinose S, Nakahama K, et al. The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis. 2005;11:1-10. (Pubitemid 41357602)
61. Thumann G, Schraermeyer U, Bartz Schmidt KU, Heimann K. Descemet's membrane as membranous support in RPE/IPE transplantation. Curr Eye Res. 1997;16(12):1236-1238. (Pubitemid 27515679)
62. Hartmann U, Sistani F, Steinhorst UH. Human and porcine anterior lens capsule as support for growing and grafting retinal pigment epithelium and iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 1999;237(11):940-945. (Pubitemid 29484170)
63. Nicolini J, Kiilgaard JF, Wiencke AK, et al. The anterior lens capsule used as support material in RPE cell-transplantation. Acta Ophthalmol Scand. 2000;78(5):527-531.
64. Lu L, Yaszemski MJ, Mikos AG. Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials. 2001;22(24):3345-3355. (Pubitemid 32923340)
65. Hadlock T, Singh S, Vacanti JP, McLaughlin BJ. Ocular cell monolayers cultured on biodegradable substrates. Tissue Eng. 1999;5(3):187-196. (Pubitemid 29296103)
66. Thomson RC, Giordano GG, Collier JH, et al. Manufacture and characterization of poly(alpha-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials. 1996;17(3):321-327. (Pubitemid 26031386)
67. Wang H, Yagi F, Cheewatrakoolpong N, Sugino IK, Zarbin MA. Short-term study of retinal pigment epithelium sheet transplants onto Bruch's membrane. Exp Eye Res. 2004;78(1):53-65. (Pubitemid 37518244)
68. Maaijwee KJ, van Meurs JC, Kirchhof B, et al. Histological evidence for revascularisation of an autologous retinal pigment epithelium-choroid graft in the pig. Br J Ophthalmol. 2007;91(4):546-550. (Pubitemid 46623693)
69. McKeever PJ, Braden TD. Comparison of full- and partial-thickness autogenous skin transplantation in dogs: a pilot study. Am J Vet Res. 1978;39(10):1706-1709.
70. Holz FG, Bindewald A, Schutt F, Specht H. Intraocular microablation of choroidal tissue by a 308 nm AIDA excimer laser for RPE-transplantation in patients with age-related macular degeneration. Biomed Tech (Berl). 2003;48(4):82-85. (Pubitemid 36505911)
71. Saari JC, Bredberg L, Garwin GG. Identification of the endogenous retinoids associated with three cellular retinoid-binding proteins from bovine retina and retinal pigment epithelium. J Biol Chem. 1982;257(22):13329-13333. (Pubitemid 13188949)
72. Saari JC, Nawrot M, Kennedy BN, et al. Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron. 2001;29(3):739-748. (Pubitemid 32323946)
73. Bunt-Milam AH, Saari JC. Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina. J Cell Biol. 1983;97(3):703-712.
74. Campochiaro PA, Hackett SF. Corneal endothelial cell matrix promotes expression of differentiated features of retinal pigmented epithelial cells: implication of laminin and basic fibroblast growth factor as active components. Exp Eye Res. 1993;57(5):539-547. (Pubitemid 23353089)
75. Daeman FJ. Veretebrate rod outer segment membranes. Biochim Biophys Acta. 1973;300(3):255-288.
76. Ostroy SE. Rhodopsin and the visual process. Biochim Biophys Acta. 1977;463(1):91-125. (Pubitemid 8122554)
77. Heitzmann H. Rhodopsin is the predominant protein of rod outer segment membranes. Nat New Biol. 1972;235(56):114.
78. Hagins WA. The visual process: excitatory mechanisms in the primary receptor cells. Annu Rev Biophys Bioeng. 1972;1:131-158.
79. Gupta BD, Goyal IC, Ghatak AK. Flash photolysis of rhodopsin in rabbit. Biophys Struct Mech. 1978;4(2):129-138. (Pubitemid 8319975)
80. Ripps H, Weale RA. Flash bleaching of rhodopsin in the human retina. J Physiol. 1969;200(1):151-159.
81. Grignolo A, Orzalesi N, Calabria GA. Studies on the fine structure and the rhodopsin cycle of the rabbit retina in experimental degeneration induced by sodium iodate. Exp Eye Res. 1966;5(1):86-97.
82. Bergstrom A, Ehinger B, Wilke K, Zucker CL, Adolph AR, Szel A. Development of cell markers in subretinal rabbit retinal transplants. Exp Eye Res. 1994;58(3):301-313. (Pubitemid 24163746)
83. Aramant R, Seiler MJ. Transplanted sheets of human retina and retinal pigment epithelium develop normally in nude rats. Exp Eye Res. 2002;75(2):115-125.
84. Davis FA. The anatomy and histology of the eye and orbit of the rabbit. Trans Am Ophthal Soc. 1929;27:401-441.
85. Del Priore LV, Kaplan HJ, Hornbeck R, Jones Z, Swinn M. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol. 1996;122(5):629-643. (Pubitemid 26371371)
86. Leonard DS, Zhang X, Panozzo G, Sugino IK, Zarbin MA. Clinicopathological correlation of localized retinal pigment epithelium debridement. Invest Ophthalmol Vis Sci. 1997;38(6):1094-1109. (Pubitemid 27227039)
87. Ivert L, Kong J, Gouras P. Changes in the choroidal circulation of rabbit following RPE removal. Greafe's Arch Clin Exp Ophthalmol. 2003;241(8):656-666. (Pubitemid 37121112)
88. Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116(2):150-154. (Pubitemid 28113313)
89. Grunwald JE, Hariprasad SM, DuPont J, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39(2):385-390. (Pubitemid 28093877)
90. Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatzsch A, Bird AC. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol. 1999;117(10):1353-1358. (Pubitemid 30029345)
91. Spraul CW, Lang GE, Grossniklaus HE. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37(13):2724-2735. (Pubitemid 27026558)
92. Harris A, Chung HS, Ciulla TA, Kagemann L. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res. 1999;18(5):669-687. (Pubitemid 29299154)